Top in GI: Acute pancreatitis and COVID-19, PPI use and asthma risk

A recent study demonstrated an increased risk for organ failure and mortality among patients with acute pancreatitis and COVID-19. It was the top story in gastroenterology last week.

Another top story was about a link between proton pump inhibitor (PPI) use and asthma risk among children. The risk for asthma was greatest among infants and toddlers aged younger than 2 years.

Read these and more top stories in gastroenterology below:

Acute pancreatitis, SARS-CoV-2 increase risk for disease severity

Patients with coexistent acute pancreatitis and SARS-CoV-2 infection had an increased risk for severe acute pancreatitis and worse clinical outcomes, according to study results. Read more.

PPI use increases risk for asthma by 57% in children

The risk for asthma in children grew with use of PPIs compared with no use, according to a study published in JAMA Pediatrics. Read more.

7 recent reports on COVID-19 in gastroenterology

Healio recently compiled a list of stories on the intersection of COVID-19 and gastroenterology. The articles include new research on how gut microbiome composition interacts with COVID-19 severity. Read more.

High rate of COVID-19 vaccination intent among IBD populations

A relatively high rate of COVID-19 vaccination intent was observed among inflammatory bowel disease populations; however, long-term safety concerns were common, according to study results. Read more.

No benefit from famotidine on COVID-19 outcomes

There was no reduced risk for COVID-19 outcomes among hospitalized patients treated with famotidine, according to study results. Read more.